Streetbeat News

OGI

OrganiGram Holdings Inc.

https://www.organigram.ca

Industry

Drug Manufacturers - Specialty & Generic

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Open

1.68

Mkt cap

179M

Volume

668K

High

1.69

P/E Ratio

-0.91

52-wk high

2.91

Low

1.63

Div yield

N/A

52-wk low

1.11

Marijuana stock movements on February 15, 2024, saw significant gains and losses across the board. ESCO Technologies led the gainers with an unprecedented rise, while EVIO topped the losers with a drastic fall. Notable companies like Aurora Cannabis and OrganiGram Holdings experienced significant drops, whereas Scotts Miracle Gro and Cronos Group saw modest gains.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 9:30 pm

The article provides a detailed list of cannabis stock gainers and losers for February 13, 2024, highlighting significant movements in the market. Notable gainers include AusCann Group Holdings with a 292.86% increase, while iAnthus Capital Holdings led the losers with a 28.57% decrease. The list includes companies from various exchanges, indicating a broad impact across the cannabis sector.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 9:30 pm

OrganiGram Holdings (NASDAQ:OGI) reported Q1 EPS of $(0.11), missing the $(0.09) estimate, and sales of $26.79M, missing the $28.00M estimate. This represents a 311.54% decrease in earnings and a 17.57% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 11:50 am

Organigram's Q1 net revenue decreased by 16% mainly due to a reduction in international revenue and medical sales.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 11:02 am

Numerous companies are scheduled to report their quarterly earnings on February 13, 2024, with expectations spanning from significant profits to losses across various sectors. Key highlights include anticipated earnings from major corporations such as Coca-Cola, Shopify, Airbnb, and Biogen, reflecting a broad spectrum of industries from technology to consumer goods. The diversity in performance indicators underscores the varying financial health and market expectations for these entities.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 10:06 am

Marijuana stocks experienced significant movements on February 12, 2024, with Canopy Growth leading the gainers with a 2607.14% increase, while AusCann Group Holdings led the losers with a 44% decrease. Notable companies like Tilray Brands and Cronos Group also saw substantial declines.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 9:30 pm

OrganiGram Holdings (NASDAQ:OGI) is scheduled to release its quarterly earnings report on February 13, 2024, with an expected EPS of $-0.13. Historical data shows mixed reactions to past earnings, with the last quarter beating estimates but resulting in a 3.94% share price drop. Over the last year, OGI shares have declined by 38.02%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 6:01 pm

Marijuana stocks experienced significant movement with ESCO Technologies, Global Hemp Group, and others among top gainers, while companies like Aurora Cannabis and OrganiGram Holdings were among the losers. The article highlights the dramatic changes in stock prices for various companies within the marijuana industry, indicating a volatile trading day.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on February 7, 2024, with ESCO Technologies leading the gainers with an unprecedented rise. The sector saw a mix of sharp increases and declines among various companies, indicating a volatile market environment for cannabis-related stocks.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:30 pm

Marijuana stocks experienced significant movements with Affinor Growers, Rhinomed, and others posting major gains, while 1933 Industries, Indiva, and others saw declines. Notably, OrganiGram Holdings, Tilray Brands, Aurora Cannabis, Cronos Group, SNDL, Psychemedics, Village Farms Intl, GrowGeneration, and Genetic Technologies were among the NASDAQ-listed companies with notable changes.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.